Compare · CARL vs MDLN
CARL vs MDLN
Side-by-side comparison of Carlsmed Inc. (CARL) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CARL and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $50.91B, about 173.4x CARL ($293.6M).
- Over the past year, CARL is down 25.3% and MDLN is down 4.8% - MDLN leads by 20.5 points.
- MDLN has been more active in the news (4 items in the past 4 weeks vs 1 for CARL).
- MDLN has more recent analyst coverage (25 ratings vs 6 for CARL).
PerformanceCARL-13.09%MDLN-4.83%
2025-12-17+0.00%2026-07-24
- Company
- Carlsmed Inc.
- Medline Inc.
- Price
- $10.86-1.00%
- $38.78+3.02%
- Market cap
- $293.6M
- $50.91B
- 1M return
- -2.07%
- +7.57%
- 1Y return
- -25.29%
- -4.83%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2025
- News (4w)
- 1
- 4
- Recent ratings
- 6
- 25
Latest CARL
- Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
- Needham initiated coverage on Carlsmed with a new price target
- Director Oboyle Kevin C was granted 13,698 shares, increasing direct ownership by 79% to 31,031 units (SEC Form 4)
- Director Sidow Kevin was granted 13,698 shares, increasing direct ownership by 23% to 73,264 units (SEC Form 4)
- Director Young Philip M was granted 13,698 shares, increasing direct ownership by 79% to 31,031 units (SEC Form 4)
- Director Root Jonathan D was granted 13,698 shares, increasing direct ownership by 3% to 497,697 units (SEC Form 4)
- Carlsmed Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 10-Q filed by Carlsmed Inc.
- Carlsmed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Carlsmed® Reports First Quarter 2026 Financial Results
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)